AnPac Bio-Medical Science Co., Ltd. logo
AnPac Bio-Medical Science Co., Ltd. ANPC
$ 4.37 -1.58%

Annual report 2022
added 12-21-2024

report update icon

AnPac Bio-Medical Science Co., Ltd. Balance Sheet 2011-2024 | ANPC

Annual Balance Sheet AnPac Bio-Medical Science Co., Ltd.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - 1.09 M - - - - - -

Long Term Debt

- - - - - - - - - - - -

Long Term Debt Current

- - - - - - - - - - - -

Total Non Current Liabilities

- - 3.09 M 2.71 M 3.72 M 15.3 M - - - - - -

Total Current Liabilities

42.3 M 62.9 M 43.5 M 66.2 M 71.4 M - - - - - - -

Total Liabilities

49.9 M 66.2 M 46.6 M 68.9 M 75.2 M 50.7 M - - - - - -

Deferred Revenue

- - 3.68 M 2.45 M 4.31 M 1.98 M - - - - - -

Retained Earnings

-578 M -476 M -357 M -276 M -174 M -132 M - - - - - -

Total Assets

40.5 M 67.5 M 49.9 M 53 M 52.8 M 60.1 M - - - - - -

Cash and Cash Equivalents

- - 3.02 M 6.12 M 12.9 M 11.4 M - - - - - -

Book Value

-9.4 M 1.32 M 3.28 M -15.9 M -22.4 M 9.5 M - - - - - -

Total Shareholders Equity

-13.7 M -4.5 M 3.28 M -15.9 M -22.4 M 9.5 M - - - - - -

All numbers in CNY currency

Quarterly Balance Sheet AnPac Bio-Medical Science Co., Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 66.2 M - 48.4 M - 46.6 M - - - 68.9 M - - - 75.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - 4.17 M - 5.09 M - 3.68 M - - - 2.45 M - - - 4.31 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -476 M - -414 M - -357 M - - - -276 M - - - -174 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 67.5 M - 69 M - 49.9 M - - - 53 M - - - 52.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 9.25 M - 8.58 M - 3.02 M - 9.97 M - 6.12 M - - - 12.9 M - - - 11.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - - - 1.32 M - 20.5 M - 3.28 M - - - -15.9 M - - - -22.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - -4.5 M - 20.9 M - 2.95 M - 24.6 M - -16 M - - - -22.4 M - - - 9.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in CNY currency